Is CTBO or RYLD a better dividend investment in 2026?

CTBO currently yields 198.02% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: CTBO offers higher current income.

What is the dividend yield difference between CTBO and RYLD?

CTBO has a forward dividend yield of 198.02% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 185.88 percentage points.

Home › Compare › CTBO vs RYLD

CTBO vs RYLD: Dividend Comparison 2026

CTBO yields 198.02% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CTBO wins by $112.65M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CTBO

● Live price

198.02%

Share price

$1.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$112.70M

Annual income

$56,534,499.65

Full CTBO calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — CTBO vs RYLD

📍 CTBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CTBO	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CTBO + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CTBO pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTBO

Annual income on $10K today (after 15% tax)

$16,831.68/yr

After 10yr DRIP, annual income (after tax)

$48,054,324.70/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, CTBO beats the other by $48,052,125.46/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTBO + RYLD for your $10,000?

CTBO: 50%RYLD: 50%

100% RYLD50/50100% CTBO

Portfolio after 10yr

$56.37M

Annual income

$28,268,543.49/yr

Blended yield

50.15%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTBO buys

RYLD buys

No recent congressional trades found for CTBO or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCTBORYLD

Forward yield	198.02% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$112.70M ✓	$44.5K
Annual income after 10y	$56,534,499.65 ✓	$2,587.35
Total dividends collected	$106.15M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CTBO vs RYLD ($10,000, DRIP)

Year	CTBO Portfolio	CTBO Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$30,502	$19,801.98	$11,914	$1,213.65	+$18.6K → CTBO
2	$89,086	$56,448.56	$14,099	$1,351.30	+$75.0K → CTBO
3	$249,403	$154,080.96	$16,580	$1,494.55	+$232.8K → CTBO
4	$670,003	$403,142.26	$19,384	$1,642.61	+$650.6K → CTBO
5	$1,729,066	$1,012,162.66	$22,535	$1,794.70	+$1.71M → CTBO
6	$4,291,289	$2,441,188.37	$26,063	$1,950.00	+$4.27M → CTBO
7	$10,253,990	$5,662,310.92	$29,995	$2,107.69	+$10.22M → CTBO
8	$23,616,660	$12,644,890.45	$34,361	$2,266.99	+$23.58M → CTBO
9	$52,487,868	$27,218,041.68	$39,194	$2,427.12	+$52.45M → CTBO
10	$112,696,518	$56,534,499.65	$44,525	$2,587.35	+$112.65M → CTBO

CTBO vs RYLD: Complete Analysis 2026

CTBO — Stock

Cantabio Pharmaceuticals, Inc., a preclinical stage biotechnology company, focuses on the research, development, and commercialization of novel therapies for Parkinson's disease (PD), Alzheimer's disease (AD), and other related diseases. Its lead programs include CB101, a DJ-1 targeting small molecule pharmacological chaperone for use in the treatment of PD; CB201, a CNS penetrant engineered DJ-1 protein for use in the treatment of PD; CB301, a Tau protein targeting small molecule pharmacological chaperone for use in the treatment of AD; and CB401, an Aß targeting small molecule pharmacological chaperone for use in the treatment of AD. The company has a collaboration agreement with Luxembourg Institute of Health to research the therapeutic targeting of the DJ-1 - protein to treat immune associated diseases. The company was founded in 2009 and is based in Palo Alto, California.

Full CTBO Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this CTBO vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTBO vs SCHD CTBO vs JEPI CTBO vs O CTBO vs KO CTBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.